Société Française de Cardiologie
11
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
18.2%
2 terminated/withdrawn out of 11 trials
77.8%
-8.7% vs industry average
9%
1 trials in Phase 3/4
0%
0 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
Use of Cardiac MRI in Early Stages of STEMI to Predict Left Ventricular Function Recovery and ICD Implantation
Role: collaborator
Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus
Role: collaborator
Relationship Between Left Ventricular Remodeling, Coronary Endothelial Function and Myocardial Fibrosis Using Positron Emission Tomography in Patients With ST-elevation Myocardial Infarction
Role: collaborator
Microparticles Circulating Plasma Concentration in Atrial Fibrillation After Percutaneous Occluding of the Left Atrium
Role: collaborator
Remote Ischemic Preconditioning Combined to Local Ischemic Postconditioning in Acute Myocardial Infarction
Role: collaborator
Evaluation of Myocardial Viability by Means of Low-dose Dobutamine Gated SPECT (the DOGS Study)
Role: collaborator
Observational Study of Heart Valve Disease in Patients With Parkinson's Disease Treated With Pergolide
Role: lead
EPOMI Study: ErythroPOietin in Myocardial Infarction
Role: collaborator
Discovery of New Circulating Biomarkers of Coronary Atherosclerosis
Role: collaborator
Diagnosis of Coronary Artery Disease in High Risk Diabetic Patients
Role: lead
Relationship Between Succinate Dehydrogenase Mutations and High-Altitude Illness
Role: lead
All 11 trials loaded